A revolutionary handheld and battery-powered DNA diagnostic device invented at the University of Otago is poised to become a commonly used field tool for rapidly detecting suspected viruses or bacteria in samples while also determining the level of infection.
The breakthrough device, dubbed Freedom4, will be unveiled today at the Queenstown Molecular Biology main meeting. It takes advantage of a technology called quantitative PCR to identify target DNA sequences in real-time, without the need for further processing.
As an example, using Freedom4, the presence and extent of norovirus infection in a sample could be confirmed within less than an hour, while the person using the unit was still at the outbreak site.
Dr Jo-Ann Stanton, who led the programme to develop the device, says that as well as enabling ‘anytime, anywhere’ clinical diagnosis of viral infectious diseases in humans and animals, it also has many other potential uses, such as border security, forensics or environmental monitoring.
Developed by Dr Stanton’s multidisciplinary team at Otago’s Department of Anatomy, the sturdy unit weighs the same as a typical laptop and fits on the palm of your hand. Freedom4 boasts a six-hour battery life and can be tethered to a laptop, or connect wirelessly to smart phones or tablets running custom software that analyses and interprets the test results.
“This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analysing samples from various locations, make their diagnoses and treat infected animals-all in one trip,” she says.
The Latest on: DNA diagnostics
via Google News
The Latest on: DNA diagnostics
- Brazilian startup seeks to develop a wholly indigenous COVID-19 diagnostic teston June 26, 2020 at 10:10 am
The project is supported by FAPESP's Innovative Research in Small Business Program. The firm plans to produce ELISA kits that will detect antibodies against the novel coronavirus in blood serum.
- Applied DNA Sciences Set to Join Russell Microcap Indexon June 26, 2020 at 4:40 am
Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic ...
- Blood test offers non-invasive brain cancer diagnosticson June 24, 2020 at 10:00 am
A non-invasive approach to the diagnosis of intracranial tumors, which currently requires high-risk surgical techniques to obtain tissue samples, has been developed by researchers from University ...
- Transplant Diagnostics Market Size to Reach Revenues of around $2 Billion by 2025 – Ariztonon June 24, 2020 at 7:42 am
Transplant diagnostics market size is expected to grow at a CAGR of ... is now being replaced by many DNA-based and sequencing-based typing methods for diagnosing various complications related to ...
- Dana-Farber researchers detect early kidney cancer with DNA methylation-screening blood teston June 22, 2020 at 8:00 am
Farber Cancer Institute found they were able to spot some of the earliest signs of kidney cancer, a potentially fatal disease that currently lacks a broad screening exam.
- Rare Disease Diagnostics: Technologies and Global Marketson June 22, 2020 at 5:40 am
The scope of the report includes rare disease diagnostic technologies, applications, industries, initiatives, patents ...
- Evaluation of CNV detection tools for NGS panel data in genetic diagnosticson June 19, 2020 at 7:14 am
Although germline copy-number variants (CNVs) are the genetic cause of multiple hereditary diseases, detecting them from targeted next-generation sequencing data (NGS) remains a challenge. Existing ...
- Cosmid DNA Isolation Market to Suffer Slight Decline in 2020, Efforts to Mitigate Coronavirus-Related Disruptions Ramp Upon June 17, 2020 at 1:08 pm
Usage in Different Techniques such as Electrophoresis and PCR to Boost the Cosmid DNA Isolation Demand The isolation of cosmid DNA is a straightforward procedure of refinement of DNA from samples ...
- Cancer treatment: personalised blood tests can better detect DNA from tumours in the body – new researchon June 17, 2020 at 11:14 am
Each person’s DNA is unique and, even more so, each tumour is genetically unique. By sequencing a person’s tumour sample or biopsy, doctors can begin to understand what DNA changes have taken place ...
- OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomicson June 17, 2020 at 4:08 am
Advances in the prediction, detection, understanding, and monitoring of human diseases have increased the use of metabolomics technologies,” said Kathleen Weber, Executive Vice President, Business ...
via Bing News